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Abstract
Background
Risk stratification is challenging in conditions, such as chest pain, shortness of breath and
syncope, which can be the manifestation of many possible underlying diseases. In these
cases, decision tools are unlikely to accurately identify all the different adverse events
related to the possible etiologies. Attribute matching is a prediction method that matches an
individual patient to a group of previously observed patients with identical characteristics
and known outcome. We used syncope as a paradigm of clinical conditions presenting with
aspecific symptoms to test the attribute matching method for the prediction of the personal-
ized risk of adverse events.
Methods
We selected the 8 predictor variables common to the individual-patient dataset of 5 prospec-
tive emergency department studies enrolling 3388 syncope patients. We calculated all pos-
sible combinations and the number of patients in each combination. We compared the
predictive accuracy of attribute matching and logistic regression. We then classified ten ran-
dom patients according to clinical judgment and attribute matching.
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Results
Attribute matching provided 253 of the 384 possible combinations in the dataset. Twelve
(4.7%), 35 (13.8%), 50 (19.8%) and 160 (63.2%) combinations had a match size�50,�30,
�20 and <10 patients, respectively. The AUC for the attribute matching and the multivariate
model were 0.59 and 0.74, respectively.
Conclusions
Attribute matching is a promising tool for personalized and flexible risk prediction. Large
databases will need to be used in future studies to test and apply the method in different
conditions.
Introduction
Clinical decision tools (CDT) combine different predictors (from patients’ history, clinical
examination and tests results) to assess the probability of a diagnosis, prognosis, or response to
treatment of an individual patient [1]. The statistical techniques used in this process are usually
based on multivariate models such as logistic regression [2]. Other approaches include recur-
sive partitioning analysis and artificial neural networks [3–5]. As they are based on models,
CDTs are able to predict the risk of any hypothetical patient, even those with a combination of
risk factors different from all the patients of the derivation cohort. Therefore, we do not know
how the CDT will perform in subjects with specific clinical presentations or needs. Indeed,
they lack the ability to provide personalized estimates as required in the era of precision medi-
cine. For example, patients with uncommon diseases are likely not to be correctly risk stratified
by CDTs. In addition, the risk estimates of composite outcomes that are usually provided by
CDTs cannot always be applied to all patients, as the definition of “acceptable risk” depends on
the patient at risk. Hence the need to assess a personalized risk rather than providing a simple
binary answer [6].
Moreover, risk stratification is challenging in conditions (as chest pain, shortness of breath
and syncope) presenting with aspecific symptoms that can be the manifestation of many possi-
ble underlying diseases. In these cases, decision tools are unlikely to accurately identify all the
different adverse events related to the possible etiologies. In syncope, which is a paradigm of
the above conditions, the traditionally derived risk stratification tools have failed in predicting
adverse events [7–12]. Here, an individualized risk assessment would allow an estimate of not
only the probability of a composite endpoint, but rather a detailed risk profile that provides the
individual risk of each specific outcome (e.g. arrhythmia or pulmonary embolism).
Attribute matching (AM) is a prediction approach that differs considerably from the regres-
sion models and has shown promising results in ruling out acute coronary syndrome and pul-
monary embolism in patients with chest pain [13–15]. Instead of considering each clinical
characteristic as an individual predictor and deriving a risk estimate based on the sum of their
regression coefficients, each individual patient is matched to a group of patients with the same
combination of the relevant clinical characteristics (or attributes) from a large reference data-
base. Therefore, each patient is matched to a group of patients with identical risk profile and
known outcomes. This approach results in a proportion (i.e. the number patients who had the
outcome of interest on the number of previously studied matched patients) that provides the
probability (with confidence interval) of the single adverse event. This process resembles the
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definition of pre-test probability by an expert clinician, which, having seen many patients who
had similar clinical characteristics as the patient under consideration, could provide an esti-
mate of the probability of something bad happening. In this case, the computer does so with
less variability and without the clinician having to be experienced nor an expert. The aim of
this study was to explore the use of AM to predict the personalized risk of adverse events and
to compare it to multivariate logistic regression to analyze the possible similarities, differences,
strengths and weaknesses of the two methods using syncope in the Emergency Department
(ED) as an example.
Materials and methods
To apply AM in a large database, we used an individual-patient dataset from a previous inter-
national collaboration that involved 3388 patients prospectively included in 5 studies enrolling
syncope patients in the ED from 2000 to 2014 [8,16–20]. The dataset was analyzed to detect
demographic and clinical variables among those considered to be relevant for syncope risk
stratification as have shown to be related to adverse events [16,17,19,21]. Each single dataset
was re-analyzed to create homogeneously defined variables for abnormal electrocardiogram
(ECG) and 7–10 day serious outcomes [7,12,22]. We finally identified the variables that were
available in all 5 datasets.
The AM estimates of the probability of serious adverse is based upon computer assisted,
database-derived system. The clinician puts in a predefined set of clinical attributes for a sub-
ject for whom the probability of a serious outcome is unknown. A computer program queries
a large patient database, and returns only the patients who share the identical attribute profile
as the patient under consideration. The proportion of these attribute-matched subjects who
had a clinical outcome of interest is the probability of adverse events.
According to the “Standardized reporting guidelines for emergency department syncope
risk-stratification research” serious outcomes included any of the following [22]: 1) all-cause
and syncope-related death, 2) ventricular fibrillation, 3) sustained and symptomatic non-sus-
tained ventricular tachycardia, 4) sinus arrest with cardiac pause > 3 s, 5) sick sinus syndrome
with alternating bradycardia and tachycardia, 6) second-degree type 2 or third-degree AV
block, 7) permanent pacemaker (PM) or implantable cardioverter defibrillator (ICD) malfunc-
tion with cardiac pauses, 8) aortic stenosis with valve area� 1 cm2, 9) hypertrophic cardiomy-
opathy with outflow tract obstruction, 10) left atrial myxoma or thrombus with outflow tract
obstruction, 11) myocardial infarction, 12) pulmonary embolism, 13) aortic dissection, 14)
occult hemorrhage or anemia requiring transfusion, 15) syncope or fall resulting in major
traumatic injury (requiring admission or procedural/surgical intervention), 16) PM or ICD
implantation, 17) cardiopulmonary resuscitation, 18) syncope recurrence with hospital admis-
sion, and 19) cerebrovascular events.
To explore the potential application of AM in this context, we calculated 1) all the unique
combinations of the selected variables (or attributes); 2) the number of combinations verified
in at least one patient in the database; 3) the number of combinations with a match size�50,
� 30,�20 and<10 patients.
The potential predictors of short-term severe outcomes were first individually evaluated
and then analyzed by multivariate logistic regression analysis with a stepwise selection strategy.
In case of one predictor was missing in one patient, it was considered as absent.
The overall diagnostic performance of both multivariate logistic regression and AM was
assessed with Receiver Operating Characteristics (ROC) curves and their area under the curve
(AUC).To exemplify how the AM would work in the real world, we considered 10 random
patients who presented with syncope, as defined according to the main international
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guidelines and consensus papers [11,12], to the ED of Fondazione IRCCS Ca’ Granda, Ospe-
dale Maggiore Policlinico, Milano from September 2015 to February 2017 [23]. For each
patient we recorded the presence or absence of any of the above attributes and calculated the
risk of adverse events according to the AM approach. For this purpose we paired the patient of
interest to the patients with an identical combination of attributes in the database and calcu-
lated the probability of adverse events as the percentage of the matched previously studied
patients who had the outcome of interest [13]. A 95% confidence interval (CI) was constructed
using the binomial distribution. As part of a larger study on syncope ED risk stratification, we
asked the ED physician to assess the patient’s risk of short-term adverse events (low, interme-
diate or high) according to his/her clinical judgement.
The data for this study were collected and analyzed anonymously. The 10 random example
patients had given written informed to have their data collected and the Internal Review Board
of L. Sacco Hospital (approval number 608/2015) had approved their use for this study pur-
pose. IRB approval was obtained by the single primary study authors.
Analyses were performed using the SAS (release 9.4) statistical software.
Results
The main characteristics of the 3388 patients included in the individual-patient database are
reported in Table 1. We identified 8 common predictors: sex, age (considered as a 3-level cate-
gorical variable: < 45 year,� 45 and< 65 years,� 65 years), trauma following syncope, pres-
ence of abnormal ECG, history of cerebrovascular disease, history of cardiac disease, history of
syncope and absence of prodrome.
Table 1. Characteristics of the included patients.
Variables EGSYS [18,24] SFSR [19] STePS [16] ROSE [17] Sun 2007 [20] Total
Total number of patients 465 684 695 1067 477 3388
Age, median (IQR) 70
(45–81)
70
(42–81)
64
(41–78)
69
(48–81)
58
(35–79)
67
(43–80)
N of admitted patients (%) 178 (38) 364 (53) 265 (38) 538 (50) 286 (60) 1631 (48)
N of men (%) 253 (54) 281 (41) 306 (44) 480 (45) 210 (44) 1530 (45)
N of patients with history of syncope (%) 195 (42) 124 (18) 389 (56) 176 (16) 160/457 (34) 1044/2931 (36)
N of patients without prodrome (%) 122 (26) 260 (38) 195 (28) 410 (38) 141 (30) 1128 (33)
N of patients with trauma following syncope (%) 133 (29) 45 (7) 162 (23) 316 (30) n.a. 656/2911 (23)
N of patients with abnormal ECG (%) 178 (38) 222 (32) 202 (29) 665 (62) 170 (36) 1437 (42)
N of patients with a history of cardiovascular disease (%) 153 (33) 139 (20) 178 (26) 284 (27) 150 (31) 904 (27)
N of patients with a history of cerebrovascular disease (%) 166 (36) 115 (17) 227 (33) n.a. 169 (35) 677/2321 (29)
N of patients with serious outcomes at 10 days (%)� 93 (20) 81 (12) 44 (6) 49 (5) 62 (13) 329 (10)
N of deaths 6 6 7 6 1 26 (1)
N of arrhythmias 31 30 20 32
N of cardiopulmonary resuscitations 5 2
N of myocardial infarctions 6 33 1
N of structural cardiopulmonary diseases 9 10 14 6
N of PM insertions or malfunctions 43 25 11 2
N of ICD insertions or malfunctions 5 2
N of haemorrhages 24 7 8
IQR: interquartile range; ECG: electrocardiogram; PM: pacemaker; ICD: Implantable Cardioverter Defibrillator; n.a.: not available.
�Some patients had more than one outcome.
https://doi.org/10.1371/journal.pone.0228725.t001
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The AM method provided 253 of the 384 possible combinations. No patient in the database
matched the remaining 131 combinations of predictors. Only 12 of the 253 (4.7%) combina-
tions had a match size�50 patients, 35 (13.8%) had a match size�30 patients, 50 (19.8%) had
a match size�20 patients, and most (160, 63.2%) had a match size <10 patients.
At univariate analysis, the risk factors significantly associated with severe short-term out-
comes were age, male gender, syncope during exertion, abnormal ECG, history of cardiovascu-
lar disease, history of cerebrovascular disease, absence of prodrome, and history of arterial
hypertension (Table 2).
At multivariate analysis, male gender, age between 45 and 65 years, age over 65 years, an
abnormal ECG, and a past medical history of cerebrovascular disease were independent risk
factors for the development of severe adverse outcomes in the short term (Table 3).
The AUC for the AM and the multivariate model were 0.59 and 0.74, respectively.
The predicted probabilities for each of the 10 patients, together with the ED physician’s per-
ceived risk are reported in Table 4. To note, none of these patients had an adverse event at
7–30 days of follow-up according to standardized criteria [22]. The detailed case description of
the 10 patients is reported in S1 Table.
Table 2. Risk factors for severe short-term outcomes within 10 days (univariate analysis).
Severe Outcomes
Yes (%) (n = 329) No (%) (n = 3059) p-value�
Male gender, n (%) 196 (60) 1334 (44) <0.0001
Age, n (%) <0.0001
< 45 years 24 (7) 869 (28)
� 45 and < 65 years 56 (17) 658 (22)
� 65 years 249 (76) 1532 (50)
Syncope during exertion, n (%) 31 (9) 187 (6) 0.0211
Trauma following syncope, n (%) 64 (19) 592 (19) 0.9651
Abnormal ECG, n (%) 229 (70) 1208 (39) <0.0001
Medical history, n (%)
Cardiovascular disease 161 (49) 743 (24) <0.0001
Cerebrovascular disease 132 (40) 545 (18) <0.0001
Arterial hypertension 154 (47) 1104 (36) 0.0001
Previous syncope 109 (33) 964 (31) 0.5491
Absence of prodrome, n (%) 126 (38) 1002 (33) 0.0430
�Chi-square test; ECG: electrocardiogram
https://doi.org/10.1371/journal.pone.0228725.t002
Table 3. Risk factors for severe short-term outcomes within 10 days at logistic multivariate regression (stepwise selection).
Adjusted Odds Ratio 95% Confidence Interval p-value�
Male gender 1.6 1.3–2.0 0.0001
Age <0.0001
< 45 years 1.0
� 45 and < 65 years 2.3 1.4–3.8
� 65 years 3.5 2.3–5.5
Abnormal ECG 2.6 2.0–3.3 <0.0001
Medical history of cerebrovascular disease 1.9 1.5–2.5 <0.0001
�Chi-square test
ECG: electrocardiogram
https://doi.org/10.1371/journal.pone.0228725.t003
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Discussion
In this paper, to assess the potential value of AM and to compare it to multivariate logistic
regression we used syncope as a paradigm of those conditions, such as chest pain and shortness
of breath, in which the creation of accurate CDTs is particularly challenging. If the condition
under consideration is the manifestation of many possible underlying diseases, CDTs are
unlikely to accurately identify all the different adverse events related to the possible etiologies
[25]. In syncope, CDTs are usually designed to identify multiple diagnoses (i.e. pulmonary
embolism, aortic dissection, high grade atrioventricular block) and adverse events that might
be related to a high number of conditions (i.e. bleeding requiring transfusion, trauma, pace-
maker implant). To increase complexity, the reference standard for diagnosis is sometimes
missing.
This study explores a method to estimate the probability of serious adverse events based on
AM. This approach allows the clinician to determine the probability of a serious outcome of a
patient based on the presence of predefined risk predictors (or attributes). This patient is
matched to all patients with the same combination of attributes included in a large reference
database. The proportion of these attribute-matched patients who had the outcome of interest
represents the estimate, with its 95% confidence interval, of the probability that such outcome
might occur in the patient under consideration [15]. This process resembles the definition of
pre-test probability by an expert clinician, which, having seen many patients who had similar
clinical characteristics as the patient under consideration, could provide an estimate of the
probability of something bad happening. In this case the computer does so with less variability
and without the clinician having to be experienced nor an expert.
The inclusion of a large number of attributes would result in very specific and detailed clini-
cal risk profiles at a cost of requiring a very large reference database. In the present work, we
used an eight-attribute profile and a 3388-patient database. Among the 384 possible combina-
tions, only 12 had a match size�50 patients and most had a match size <10 patients. There-
fore, our data do not offer a clinically useful prediction tool at this stage and the AUC shows
that logistic regression is superior if derived from the dataset we used, but this method seems
promising, as it has some advantages as compared to model-derived clinical decision tools.
Table 4. Predicted probabilities according to attribute matching and clinical judgement in the 10 example
patients.
Case n Attribute matching ED physician
patients at risk� 10-day SAE, % (95% CI)
1 15 20 (7–45) High risk
2 70 4 (1–12) Intermediate risk
3 42 5 (1–16) Intermediate risk
4 12 0 (0–24) Intermediate risk
5 84 4 (1–10) Intermediate risk
6 34 6 (2–19) Low risk
7 42 5 (1–16) High risk
8 6 16 (3–56) High risk
9 6 0 (0–39) High risk
10 3 33 (6–79) High risk
ED: Emergency Department; SAE: serious adverse events
�: number of patients with the same combination of risk factors
CI: Confidence Interval.
https://doi.org/10.1371/journal.pone.0228725.t004
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Indeed, the successful use of a model to predict the probability of a serious outcome requires
that the results are reproduced in an external validation so that both the external validity and
robustness of the model are verified. Moreover, models require that the predictors are assigned
a weight that allow to estimate the risk of adverse events in every patient, also in those that had
no matching subject in the derivation database (for example for patients that have a rare condi-
tion). Attribute matching differs from scoring systems derived from logistic regression, which
use predictor variables expressed by an individual patient under consideration to guide that
patient into a predefined category that predicts a probability. This outcome probability is esti-
mated from knowledge (i.e., the magnitude of importance of predictor variables) manifested
by the patients that were used to construct the model. On the other hand, attribute matching
works in reverse fashion. Instead of placing the patient under consideration into a category,
the computer program finds the patients from a reference database who ‘‘look like” the patient
insofar as they are identical on the binary predictor variables. Therefore, the risk of patients
with an uncommon combination of predictors, might not be able at all to find a match in the
derivation dataset. However, being aware that the patient’s estimated probability might be
based on very limited evidence, will allow both the clinician and the patient to take a decision
conscious that it might be based on uncertainty, rather than deciding on the false confidence
provided by models.
Several thousands of subjects need to be enrolled for acceptable AM risk prediction. If this
was the case, only administrative databases could be used to use AM for risk prediction. In the
era of big data and with the increase in the availability and accuracy of population-based data-
bases, this might not be a barrier to the use of AM for risk prediction in several conditions [26].
AM has several advantages: 1) The possibility to have as output not only the probability of a
composite serious outcome, but a detailed patient specific risk profile based on the probability
of different outcomes allowing for a more personalized decision making. Also, the possibility
to make the risk profile explicit and more personalized could allow for more meaningful
shared decision making with the patient; 2) as there is no need for model fitting, patients could
be always added to the dataset thus increasing the probability estimate precision; 3) the flexibil-
ity of AM would allow to consider different predictors in different patients, thus allowing an
individualized estimate; 4) as there is no statistical modelling, the reliability of the results is
based on the similarity between the population of the reference database and every-day
patients rather than on complex statistical calculations; 5) the prediction tools based on mod-
els, such as logistic regression and neural networks provide a risk estimate in every case, also in
patients whose combination of clinical characteristics are different from each patient’s combi-
nation in the derivation cohort, giving the physician a false confidence. Conversely, AM would
allow both the clinician and the patient to make a decision being aware that it might be based
on uncertainty, rather than deciding on the false confidence provided by models. This is cru-
cial in the perspective of a modern medicine increasingly based on personalized and shared
decision making.
AM has also some important limitations: 1) to be used in clinical practice the reference
database should include a large number of patients; 2) the choice of predictors is crucial for the
successful application of the method; 3) AM will promote personalized medicine, providing
the probability of events, rather than a clear indication of what to do (i.e. admit vs discharge).
However, the need to interpret and apply the estimated probability to the context may be felt
as a limitation due to lack of certainty; 4) a score is easy to remember and apply, while AM
requires data collection and computer input ideally through a computer/smartphone app. Fur-
thermore, the value of CDT as early and necessary work to determine the choice of predictors
to be considered should not be under estimated as they help determine what attributes and fac-
tors should be collected and used for AM.
Syncope risk prediction through attribute matching
PLOS ONE | https://doi.org/10.1371/journal.pone.0228725 March 18, 2020 7 / 11
Some limitations of the present study should be acknowledged. The database we used was
collected for different purposes and, although we did our best to homogenize the data, we
could not overcome some heterogeneity among the single studies’ dataset. Also, we used as
predictors the eight variables in common between the original datasets with no a priori deci-
sion on the number of predictors to be selected. However, this number strongly influences the
sample size of the population to be included in the AM database. Nonetheless, it must be
pointed out that syncope and this database were used only as a working example to show the
possible applications of AM.
Conclusions
In conclusion, our study shows that the AM is a promising method to predict the risk of
adverse events in clinical practice and could offer some advantages as compared with standard
methods based on logistic regression. However, large datasets are required to obtain a precise
and informative estimate. Future studies should explore the use of administrative databased or
big data in conditions in which there is less clinical heterogeneity to use AM and to compare it
with the traditional risk stratification tools.
Supporting information
S1 Table. Example clinical cases with the probabilities predicted by attribute matching and
clinical judgement. BP: blood pressure; HR: heart rate; ECG: electrocardiogram; ED: Emer-
gency Department; CI: Confidence Interval.
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